CooperCompanies, US2166485019

Stifel reiterates Buy for CooperCompanies stock

Published on 10/05/2026 at 12:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stifel sets a USD 70.00 target on October 1, 2026. CooperCompanies stock costs EUR 50.70 on October 5, 2026 after EUR 50.57, plus 0.26 percent.

Reinraum-Produktionsanlage für medizinische Geräte mit Technikern an Kontaktlinsen-Fertigungslinien
CooperCompanies Reinraum-Produktion US21664P1039 zeigt automatisierte Kontaktlinsen-Fertigungslinien mit optischer Qualitätsprüfung im sterilen Reinraumbereich, Illustration mit AI erstellt.

CooperCompanies (ISIN US2166485019) was trading at EUR 50.70 at Lang & Schwarz on October 5, 2026 at 12:15 p.m. CEST, up 0.26 percent versus the prior close of EUR 50.57. Investing.com reported on October 1, 2026 that Stifel maintained its Buy rating and a USD 70.00 price target.

Third-quarter revenue reached USD 1.066 billion

In its fiscal third quarter ended July 31, 2026, CooperCompanies generated revenue of USD 1.066 billion, an increase of 1.00 percent from the prior-year quarter. The company reported GAAP diluted earnings per share of USD 2.24, versus USD 0.49 a year earlier, while non-GAAP diluted earnings per share rose 4.00 percent to USD 1.15, according to the CooperCompanies release dated September 9, 2026.

The earnings mix matters. CooperVision revenue was USD 717.0 million and unchanged from the prior-year quarter, while CooperSurgical revenue increased 2.00 percent to USD 349.2 million and grew 3.00 percent organically, according to the same release.

Fiscal guidance stays in a narrow range

Management guided to fiscal 2026 revenue of USD 4.229 billion to USD 4.252 billion, representing organic growth of 2.00 percent to 3.00 percent. The company also expects fiscal 2026 non-GAAP diluted earnings per share of USD 4.51 to USD 4.55 and reaffirmed a free cash flow objective exceeding USD 2.2 billion for fiscal years 2026 through 2028.

The comparison with expectations is mixed. MarketBeat reported that Zacks Research cut its fiscal 2026 earnings estimate from USD 4.61 to USD 4.53 per share on September 29, 2026, while the latest company guidance spans USD 4.51 to USD 4.55.

Analysts see a split outlook

Stifel's USD 70.00 target remains above its USD 56.91 Nasdaq reference price on October 2, 2026, but the target and the Lang & Schwarz quote use different currencies. The Nasdaq 52-week range was USD 51.01 to USD 89.83, and market capitalization stood at USD 11.1 billion on October 2, 2026.

MarketBeat said 19 brokerages covered the company, with 12 Hold ratings, five Buy ratings and two Sell ratings. That distribution puts the recent guidance in context: the business is still producing positive organic growth, but CooperVision's flat quarterly revenue and the narrow fiscal growth range leave less room for execution setbacks.

Stock remains near its yearly low

CooperCompanies stock was trading at EUR 50.70 at Lang & Schwarz on October 5, 2026 at 12:15 p.m. CEST, plus 0.26 percent versus the prior close of EUR 50.57. The further course of trading is shown by the continuously updated real-time quote of CooperCompanies stock.

CooperCompanies stock facts

  • Company: The Cooper Companies, Inc.
  • ISIN: US2166485019
  • Ticker: COO
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz as of October 5, 2026, 12:15 p.m. CEST: EUR 50.70
  • Change versus prior close: plus 0.26 percent
  • Prior close Lang & Schwarz October 2, 2026: EUR 50.57
  • Market capitalization: USD 11.1 billion as of October 2, 2026
  • 52-week range: USD 51.01-89.83 as of October 2, 2026
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

More news and analyses on CooperCompanies stock

Disclaimer...

en | US2166485019 | COOPERCOMPANIES | boerse | 70232218 | bgmi